These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dementia with Lewy bodies and Parkinson disease with dementia: can MRI make the difference? Seppi K; Rascol O Neurology; 2007 Aug; 69(8):717-8. PubMed ID: 17709701 [No Abstract] [Full Text] [Related]
3. Neuropathology of Lewy body disorders. Kövari E; Horvath J; Bouras C Brain Res Bull; 2009 Oct; 80(4-5):203-10. PubMed ID: 19576266 [TBL] [Abstract][Full Text] [Related]
4. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Gai WP; Yuan HX; Li XQ; Power JT; Blumbergs PC; Jensen PH Exp Neurol; 2000 Dec; 166(2):324-33. PubMed ID: 11085897 [TBL] [Abstract][Full Text] [Related]
5. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies. Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907 [TBL] [Abstract][Full Text] [Related]
6. Re: In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Jellinger KA Neurology; 2008 Jan; 70(5):407-8. PubMed ID: 18227426 [No Abstract] [Full Text] [Related]
7. Lewy bodies in Parkinson's disease: protectors or perpetrators? Harrower TP; Michell AW; Barker RA Exp Neurol; 2005 Sep; 195(1):1-6. PubMed ID: 16023637 [No Abstract] [Full Text] [Related]
8. Propagation of host disease to grafted neurons: accumulating evidence. Kordower JH; Brundin P Exp Neurol; 2009 Dec; 220(2):224-5. PubMed ID: 19786018 [No Abstract] [Full Text] [Related]
10. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Weisman D; Cho M; Taylor C; Adame A; Thal LJ; Hansen LA Neurology; 2007 Jul; 69(4):356-9. PubMed ID: 17646627 [TBL] [Abstract][Full Text] [Related]
11. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods. Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542 [TBL] [Abstract][Full Text] [Related]
12. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Beyer MK; Larsen JP; Aarsland D Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706 [TBL] [Abstract][Full Text] [Related]
13. Overview of the extranigral aspects of Parkinson disease. Lim SY; Fox SH; Lang AE Arch Neurol; 2009 Feb; 66(2):167-72. PubMed ID: 19204152 [TBL] [Abstract][Full Text] [Related]
14. Are Lewy bodies non-specific epiphenomena of nigral damage? Wenning G; Quinn N Mov Disord; 1994 May; 9(3):378-9. PubMed ID: 8041389 [No Abstract] [Full Text] [Related]
15. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD. Jellinger KA Parkinsonism Relat Disord; 2006 Mar; 12(2):119-20. PubMed ID: 16337163 [No Abstract] [Full Text] [Related]